Completed PHASE4 INTERVENTIONAL 2-arm NCT05660694

Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis

Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis: A Clinical Trial

Sponsor: Altamash Institute of Dental Medicine

Conditions Oral Submucosa Fibrosis Pentoxifylline Triamcinolone Tumor Vitamin E

Interventions Pentoxifylline with Vitamin E Triamcinolone

Updated 3 times since 2023 Last updated: Dec 13, 2022 Started: Jan 1, 2020 Primary completion: Sep 30, 2021 Completion: Sep 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Oral Submucosa Fibrosis and Pentoxifylline and is currently completed. Altamash Institute of Dental Medicine leads this study, which shows 3 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4

First recorded

Jan 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Altamash Institute of Dental Medicine

Data source: Altamash Institute of Dental Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Karachi, Pakistan